Morgan Stanley’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $512 | Sell |
|
|||||
|
2025
Q1 | $585 | Sell |
|
|||||
|
2024
Q4 | $8.94K | Sell |
|
|||||
|
2024
Q3 | $123K | Sell |
|
|||||
|
2024
Q2 | $139K | Sell |
|
|||||
|
2024
Q1 | $560K | Sell |
|
|||||
|
2023
Q4 | $746K | Buy |
|
|||||
|
2023
Q3 | $370K | Sell |
|
|||||
|
2023
Q2 | $499K | Sell |
|
|||||
|
2023
Q1 | $786K | Sell |
|
|||||
|
2022
Q4 | $1.71M | Buy |
|
|||||
|
2022
Q3 | $10.8M | Sell |
|
|||||
|
2022
Q2 | $5.99M | Buy |
|
|||||
|
2022
Q1 | $7.18M | Sell |
|
|||||
|
2021
Q4 | $12.9M | Buy |
|
|||||
|
2021
Q3 | $11.8M | Buy |
|
|||||
|
2021
Q2 | $844K | Buy |
|
|||||
|
2021
Q1 | $41K | Sell |
|
|||||
|
2020
Q4 | $373K | Sell |
|
|||||
|
2020
Q3 | $506K | Sell |
|
|||||
|
2020
Q2 | $2.05M | Buy |
|
|||||
|
2020
Q1 | $26K | Sell |
|
|||||
|
2019
Q4 | $263K | Buy |
|